Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome characterized by excessive deposition of fatty acids in the liver. Further deterioration leads to nonalcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma, creating a heavy burden on human health and the social economy. Currently, there are no effective and specific drugs for the treatment of NAFLD. Therefore, it is important to further investigate the pathogenesis of NAFLD and explore effective therapeutic targets for the prevention and treatment of the disease. Six-transmembrane epithelial antigen of prostate 3 (STEAP3), a STEAP family protein, is a metalloreductase. Studies have shown that it can participate in the regulation of liver ischemia-reperfusion injury, hepatocellular carcinoma, myocardial hypertrophy, and other diseases. In this study, we found that the expression of STEAP3 is upregulated in NAFLD. Deletion of STEAP3 inhibits the development of NAFLD in vivo and in vitro, whereas its overexpression promotes palmitic acid/oleic acid stimulation-induced lipid deposition in hepatocytes. Mechanistically, it interacts with transforming growth factor beta-activated kinase 1 (TAK1) to regulate the progression of NAFLD by promoting TAK1 phosphorylation and activating the TAK1-c-Jun N-terminal kinase/p38 signaling pathway. Taken together, our results provide further insight into the involvement of STEAP3 in liver pathology.

• Authors: Ting Ding, Siping Chen, Wenchang Xiao, Zhen Liu, Jun Tu, Yongjie Yu, Bizhen Dong, Wenping Chen, Yong Zeng
• Journal: Journal of lipid research (J Lipid Res) Vol. 64 Issue 1 Pg. 100318 (01 2023) ISSN: 1539-7262 [Electronic] United States
• PMID: 36495944 (Publication Type: Journal Article)
• Copyright: Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Chemical References

• STEAP3 protein, human

Topics

• Humans
• Male
• Carcinoma, Hepatocellular (pathology)
• Hepatocytes (metabolism)
• Insulin Resistance
• Liver (metabolism)
• Liver Neoplasms (pathology)
• Non-alcoholic Fatty Liver Disease (metabolism)
• Prostate (metabolism)